Follow The Filings

MDWD MediWound

MediWound earnings company data as of 4:49 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 19 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.80 —
Rev — — —

Insider trades

Open-market buys and sales by MDWD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MDWD insider trades
  • $143K bought by 3 insiders
  • $82K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Samuel Rubinstein Director
    Buy
    $6,626 525 shares at $12.62 New stake
    Traded Sep 1 Filed Sep 2
    ↗
  2. Samuel Rubinstein Director
    Sale
    $6,678 525 shares at $12.72 100% of stake
    Traded Sep 1 Filed Sep 2
    ↗
  3. Shmuel Hess COO
    Sale
    $75K 5,823 shares at $12.95 100% of stake
    Traded Aug 26–27 Filed Aug 28
    ↗
  4. Nachum Shamir Director
    Buy
    $84K 6,000 shares at $14.00 +12% to stake
    Traded Jun 3 Filed Jun 4
    ↗
  5. David Morton Fox Director
    Buy
    $50K 3,537 shares at $14.11 +19% to stake
    Traded Jun 1 Filed Jun 2
    ↗
  6. Samuel Rubinstein Director
    Buy
    $2,150 150 shares at $14.33 +5.3% to stake
    Traded May 29 Filed Jun 1
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K Filing Doc
6-K Filing Doc
SCHEDULE 13G — Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
20-F Filing Doc
6-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
424B5 Filing Doc
6-K Filing Doc
6-K Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.